Logos Global Management LP Cerevel Therapeutics Holdings, Inc. Transaction History

Logos Global Management LP

  • $761 Million
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$20.26 - $31.91 $14.2 Million - $22.3 Million
700,000 New
700,000 $15.3 Million
Q4 2022

Feb 14, 2023
BUY
$25.35 - $31.96 $6.59 Million - $8.31 Million
260,000 New
260,000 $8.2 Million
Q1 2021

May 17, 2021
SELL
$12.37 - $17.74 $1.24 Million - $1.77 Million
-100,000 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$9.82 - $18.27 $982,000 - $1.83 Million
100,000 New
100,000 $1.66 Million

Others Institutions Holding CERE

# of Institutions
7
Shares Held
5.01M
Call Options Held
3.3K
Put Options Held
0
View Full List

About Cerevel Therapeutics Holdings, Inc.

CERE Quotes by TradingView
  • Ticker CERE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 155,752,000
  • Description
  • Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-...
More about CERE
Track This Portfolio

Track Logos Global Management LP Portfolio

Follow Logos Global Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Logos Global Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email